vranckx pascal retweeted
Teaming up again with the great @VerwerftJan to share our experience with #echoCPET in #HFpEF. This hot-of-the-press paper @ESC_Journals demonstrates myriad of opportunities for diagnosis & treatment, far beyond #SGLT2i only. Tweetorial below!
@SarahStroobant2 @HerbotsLieven
vranckx pascal retweeted
#ACC23 now!!!
Opening sessions tomorrow Don’t miss this. Lets meet in person 😊
vranckx pascal retweeted
Really excited to present our latest paper @JACCJournals on how to organize a #dyspnoeaclinic for #HFpEF! Tweetorial below...
sciencedirect.com/science/ar…
Implementation perspective = new item in #JACCHeartFail under @BiykemB leadership! Really the clinician's voice, just love it!
vranckx pascal retweeted
We just made it! #ECLS-SHOCK last patient in just happened!!! Congrats to the whole team! Another milestone in #cardiogenicshock treatment! @AGIKinterv @KardiologieHH @TRassafMD @YoungDgk @DGK_org @AnneFreund3 @hvanspall
vranckx pascal retweeted
Saddle PE WITH LARGE CLOT in transit! Completely removed! Big RA thrombus could probably have lead to PEA arrest
RV:LV 2:1, elevated lactate/Troponin/BNP, PAP 80s on echo (normal recently)…
(see echo below).
vranckx pascal retweeted
Really proud moment for me today, presenting 1st time in a Featured Science session @AHAScience.
Deeper insight in #ADVOR trial with key contributions from @WilfriedMullens @PieterMartensMD @JeroenDauw @petra_nijst @EvelyneMeekers among many others. Proudly 🇧🇪!
Tweetorial below!
vranckx pascal retweeted
Must be my hottest #AHA in the Windy City, beautiful skyline yesterday from Navy pier! Getting ready for my first LBT @AHAScience. Eager to learn results from TRANSFORM-HF! Some great science on #diuretics this meeting!
Stay tuned for #ADVOR analyses tomorrow @PieterMartensMD
vranckx pascal retweeted
SPOT the DIAGNOSIS is 1 year #EHJACVC @ESC_Journals ! 🥳 We had some great submissions coming in, please continue to send us your materials and get in touch with our readership…
@pascal_vranckx @EHJACVCEiC @krychtiukmd
vranckx pascal retweeted
Incredibly sad news. I completely share you view Gregg, interacting with him and learning from him was even better than having the manuscript finally accepted in the journal. RIP John and thank you for pushing me to dedicate MASTER DAPT to my parents at ESC presentation.
vranckx pascal retweeted
We got nearly 400 votes in, interesting result with a clear winner. However, I would argue that 83% of you have this wrong, explanation below…
Replying to @FH_Verbrugge
If you have understood this well, who gets vasodilator therapy from you?
15%BP 90/70 PAWP 28 CVP 12
64%BP 90/70 PAWP 28 CVP 24
4%BP 110/60 PAWP 28 CVP 12
17%BP 160/100 PAWP 28 CVP 12
741 votes • Final results vranckx pascal retweeted
We should more frequently be brave and withdraw the manuscript when we encounter reviewers who simply want to show how good they are or even worse have intellectual biases…editors will start recognizing them and reviewers will stop destroying manuscripts just for the sake of..
This Post is from an account that no longer exists. Learn more
vranckx pascal retweeted
In this issue of JACC interventions, three papers examine the outcomes of TEER in patients with Atrial FMR.
Sonia Petronio, @hahn_rt, and myself wrote a combo editorial/mini review discussing the 3 papers & the nuances of studying aFMR in general jacc.org/doi/10.1016/j.jcin.…
vranckx pascal retweeted
Two‐year clinical outcomes after successful transcatheter aortic valve implantation with balloon‐expandable versus self‐expanding valves: A subanalysis of the GALILEO trial onlinelibrary.wiley.com/doi/…
vranckx pascal retweeted
3 min to go for the great debate on mechanical circulatory support! #ESCCongress @seanvandiepen @susannaprice @CHassager @AGIKinterv @mmamas1973
vranckx pascal retweeted
Final 15 month results of MASTER DAPT on their way today at ESC…ready for additional information on how well or bad 1 month DAPT looks like in HBR patients at long-term? @masterdapt @mirvatalasnag @mmamas1973
vranckx pascal retweeted
Odyssey outcomes analysis presented today @Esc2022. Baseline lp(a) predicts revascularisation. Importantly, benefit of alirocumab in reducing revascularization appeared confined to patients with elevated lp(a), despite similar baseline and achieved LDL-c across quartiles 1/2
vranckx pascal retweeted
Vitamin K antagonists better than rivaroxaban in INVICTUS. The mechanism of (late) benefit (i.e., less death, sudden death or death due to mechanical or pump failure) is unclear: no difference in bleeding, not enough difference in stroke. #ESCCongress nejm.org/doi/full/10.1056/NE…
vranckx pascal retweeted
Steffen Desch is making an excellent overview of #TOMAHAWK
Very good algorithm how to manage these pts #OHCA #angio #CPR
#ESCCongress @susannaprice @rafavidalperez @CVandenbriele @mirvatalasnag @umityasarsinan1 @JohannesGrand @pascal_vranckx @saskavaska
vranckx pascal retweeted
Highlight of my career so far! From an idea conceptualised during my PhD, cultivated by 4 generations of PhD students after me under the watch of @WilfriedMullens, to a @NEJM publication and novel treatment for acute #HeartFailure
#acetazolamide #advor
nejm.org/doi/full/10.1056/NE…


























